Takao Koichi, Toda Kazuhiro, Saito Takayuki, Sugita Yoshiaki
Laboratory of Bioorganic Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
Chem Pharm Bull (Tokyo). 2017;65(11):1020-1027. doi: 10.1248/cpb.c17-00416.
A series of cinnamic acid derivatives, amides (1-12) and esters (13-22), were synthesized, and structure-activity relationships for antioxidant activity, and monoamine oxidases (MAO) A and B, acetylcholinesterase, and butyrylcholinesterase (BChE) inhibitory activities were analyzed. Among the synthesized compounds, compounds 1-10, 12-18, and rosmarinic acid (23), which contained catechol, o-methoxyphenol or 5-hydroxyindole moieties, showed potent 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity. Compounds 9-11, 15, 17-22 showed potent and selective MAO-B inhibitory activity. Compound 20 was the most potent inhibitor of MAO-B. Compounds 18 and 21 showed moderate BChE inhibitory activity. In addition, compound 18 showed potent antioxidant activity and MAO-B inhibitory activity. In a comparison of the cinnamic acid amides and esters, the amides exhibited more potent DPPH free radical scavenging activity, while the esters showed stronger inhibitory activities against MAO-B and BChE. These results suggested that cinnamic acid derivatives such as compound 18, p-coumaric acid 3,4-dihydroxyphenethyl ester, and compound 20, p-coumaric acid phenethyl ester, may serve as lead compounds for the development of novel MAO-B inhibitors and candidate lead compounds for the prevention or treatment of Alzheimer's disease.
合成了一系列肉桂酸衍生物,包括酰胺(1-12)和酯(13-22),并分析了其抗氧化活性、单胺氧化酶(MAO)A和B、乙酰胆碱酯酶以及丁酰胆碱酯酶(BChE)抑制活性的构效关系。在合成的化合物中,含有儿茶酚、邻甲氧基苯酚或5-羟基吲哚部分的化合物1-10、12-18和迷迭香酸(23)表现出较强的1,1-二苯基-2-苦基肼(DPPH)自由基清除活性。化合物9-11、15、17-22表现出较强的选择性MAO-B抑制活性。化合物20是最有效的MAO-B抑制剂。化合物18和21表现出中等程度的BChE抑制活性。此外,化合物18表现出较强的抗氧化活性和MAO-B抑制活性。在肉桂酸酰胺和酯的比较中,酰胺表现出更强的DPPH自由基清除活性,而酯对MAO-B和BChE表现出更强的抑制活性。这些结果表明,肉桂酸衍生物如化合物18、对香豆酸3,4-二羟基苯乙酯和化合物20、对香豆酸苯乙酯,可能作为新型MAO-B抑制剂开发的先导化合物以及预防或治疗阿尔茨海默病的候选先导化合物。